Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Moderate to Severe Plaque Psoriasis in Chinese Patients
CTR20130367Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Apr 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of adalimumab in plaque psoriasis, sponsored by Abbott Laboratories. Started Apr 2014; status: completed.
02
Drugs
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on CTR20130367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130367.